Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Bingham

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Analytical Biochemistry|March 11, 2006
A fluorescence polarization assay for screening inhibitors against the ribonuclease H activity of HIV-1 reverse transcriptaseGrace R Nakayama, Patrick Bingham, Douglas Tan, et al.
Assay and Drug Development Technologies|June 13, 2015
Comparison of a High-Throughput Mass Spectrometry Method and Radioactive Filter Binding to Assay the Protein Methyltransferase PRMT5Karen A Maegley, Cody Krivacic, Patrick Bingham, et al.
Combinatorial Chemistry & High Throughput Screening|June 22, 2006
Analysing the output from primary screeningDawn Nowlin, Patrick Bingham, Andrew Berridge, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2015
SAH derived potent and selective EZH2 inhibitorsPei-Pei Kung, Buwen Huang, Luke Zehnder, et al.
The Journal of Biological Chemistry|February 5, 2025
Modulation of the substrate preference of a MYST acetyltransferase by a scaffold proteinRaghuvir N Sengupta, Oleg Brodsky, Patrick Bingham, et al.
Nature Communications|April 29, 2016
Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistanceAlexei Brooun, Ketan S Gajiwala, Ya-Li Deng, et al.
Journal of Medicinal Chemistry|November 8, 2017
Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical CandidateStefano Crosignani, Patrick Bingham, Pauline Bottemanne, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Characterization of Specific <i>N</i>-α-Acetyltransferase 50 (Naa50) Inhibitors Identified Using a DNA Encoded LibraryPei-Pei Kung, Patrick Bingham, Benjamin J Burke, et al.
Journal of Medicinal Chemistry|August 12, 2016
Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) InhibitorsPei-Pei Kung, Eugene Rui, Simon Bergqvist, et al.
Journal of Medicinal Chemistry|December 13, 2016
Correction to Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) InhibitorsPei-Pei Kung, Eugene Rui, Simon Bergqvist, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Analytical Biochemistry|March 11, 2006
A fluorescence polarization assay for screening inhibitors against the ribonuclease H activity of HIV-1 reverse transcriptaseGrace R Nakayama, Patrick Bingham, Douglas Tan, et al.
Assay and Drug Development Technologies|June 13, 2015
Comparison of a High-Throughput Mass Spectrometry Method and Radioactive Filter Binding to Assay the Protein Methyltransferase PRMT5Karen A Maegley, Cody Krivacic, Patrick Bingham, et al.
Combinatorial Chemistry & High Throughput Screening|June 22, 2006
Analysing the output from primary screeningDawn Nowlin, Patrick Bingham, Andrew Berridge, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2015
SAH derived potent and selective EZH2 inhibitorsPei-Pei Kung, Buwen Huang, Luke Zehnder, et al.
The Journal of Biological Chemistry|February 5, 2025
Modulation of the substrate preference of a MYST acetyltransferase by a scaffold proteinRaghuvir N Sengupta, Oleg Brodsky, Patrick Bingham, et al.
Nature Communications|April 29, 2016
Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistanceAlexei Brooun, Ketan S Gajiwala, Ya-Li Deng, et al.
Journal of Medicinal Chemistry|November 8, 2017
Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical CandidateStefano Crosignani, Patrick Bingham, Pauline Bottemanne, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Characterization of Specific <i>N</i>-α-Acetyltransferase 50 (Naa50) Inhibitors Identified Using a DNA Encoded LibraryPei-Pei Kung, Patrick Bingham, Benjamin J Burke, et al.
Journal of Medicinal Chemistry|August 12, 2016
Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) InhibitorsPei-Pei Kung, Eugene Rui, Simon Bergqvist, et al.
Journal of Medicinal Chemistry|December 13, 2016
Correction to Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) InhibitorsPei-Pei Kung, Eugene Rui, Simon Bergqvist, et al.
Pageof 2